Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Humblet

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Progress in Histochemistry and Cytochemistry|January 1, 1992
Ontogeny of T-cell surface molecules and receptors in the thymusM P Defresne, C Humblet, J Deman, et al.
Biochemistry|September 8, 1992
X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitorsJ Cooper, W Quail, C Frazao, et al.
Journal of Medicinal Chemistry|June 25, 1993
Multiple binding modes for the receptor-bound conformations of cyclic AII agonistsK Plucinska, T Kataoka, M Yodo, et al.
Journal of Medicinal Chemistry|August 19, 1994
A novel nonpeptide HIV-1 protease inhibitor: elucidation of the binding mode and its application in the design of related analogsE A Lunney, S E Hagen, J M Domagala, et al.
Molecular Pharmacology|October 1, 1995
Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptorF Z Chung, L H Wu, Y Tian, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Journal of Medicinal Chemistry|September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variationC M Rao, P E Scarborough, J Kay, et al.
Journal of Medicinal Chemistry|February 12, 2000
Structural basis of the thrombin selectivity of a ligand that contains the constrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl- piperidin-3-yl)-propanoic acid at P1L S Narasimhan, J R Rubin, D R Holland, et al.
Journal of Molecular Biology|November 4, 2000
X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificityN B Cronin, M O Badasso, I J Tickle, et al.
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Progress in Histochemistry and Cytochemistry|January 1, 1992
Ontogeny of T-cell surface molecules and receptors in the thymusM P Defresne, C Humblet, J Deman, et al.
Biochemistry|September 8, 1992
X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitorsJ Cooper, W Quail, C Frazao, et al.
Journal of Medicinal Chemistry|June 25, 1993
Multiple binding modes for the receptor-bound conformations of cyclic AII agonistsK Plucinska, T Kataoka, M Yodo, et al.
Journal of Medicinal Chemistry|August 19, 1994
A novel nonpeptide HIV-1 protease inhibitor: elucidation of the binding mode and its application in the design of related analogsE A Lunney, S E Hagen, J M Domagala, et al.
Molecular Pharmacology|October 1, 1995
Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptorF Z Chung, L H Wu, Y Tian, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Journal of Medicinal Chemistry|September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variationC M Rao, P E Scarborough, J Kay, et al.
Journal of Medicinal Chemistry|February 12, 2000
Structural basis of the thrombin selectivity of a ligand that contains the constrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl- piperidin-3-yl)-propanoic acid at P1L S Narasimhan, J R Rubin, D R Holland, et al.
Journal of Molecular Biology|November 4, 2000
X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificityN B Cronin, M O Badasso, I J Tickle, et al.
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Pageof 8